Literature DB >> 28639813

Contingency management interventions for tobacco and other substance use disorders in pregnancy.

Dennis J Hand1, Jennifer D Ellis2, Meagan M Carr2, Diane J Abatemarco1, David M Ledgerwood2.   

Abstract

Contingency management (CM) is an effective intervention for reducing use of licit and illicit substances in a variety of populations. Pregnant women are a vulnerable population with much to gain from effective interventions for substance use disorders, and for whom CM interventions may be especially well-suited. We reviewed the literature on CM interventions among pregnant women with tobacco and other substance use disorders with 3 aims: (a) describe the effectiveness of CM for reducing use of tobacco and other substances during pregnancy, (b) describe the effects of CM interventions on infant outcomes, and (c) identify needs for future research on CM in pregnancy. Our search strategy revealed 27 primary studies of CM in pregnancy. CM was effective in the majority of studies targeting nicotine abstinence, and results were mixed in studies targeting illicit substances. A variety of methodologies were used within the relatively small number of studies making it difficult to identify underlying mechanisms. Also, very few studies reported maternal and infant outcomes, and significant effects of CM were only apparent when secondary analyses pooled data from multiple studies. Furthermore, there is extremely limited data on the cost effectiveness of CM interventions in pregnancy. Future research should address these 3 areas to better determine the ultimate value of CM as an efficacious treatment for pregnant women with substance use disorders. (PsycINFO Database Record (c) 2017 APA, all rights reserved).

Entities:  

Mesh:

Year:  2017        PMID: 28639813      PMCID: PMC5714659          DOI: 10.1037/adb0000291

Source DB:  PubMed          Journal:  Psychol Addict Behav        ISSN: 0893-164X


  75 in total

1.  Predictors of smoking cessation in pregnancy and maintenance postpartum in low-income women.

Authors:  Yunsheng Ma; Karin Valentine Goins; Lori Pbert; Judith K Ockene
Journal:  Matern Child Health J       Date:  2005-12

2.  Financial incentives for smoking cessation in pregnancy: randomised controlled trial.

Authors:  David Tappin; Linda Bauld; David Purves; Kathleen Boyd; Lesley Sinclair; Susan MacAskill; Jennifer McKell; Brenda Friel; Alex McConnachie; Linda de Caestecker; Carol Tannahill; Andrew Radley; Tim Coleman
Journal:  BMJ       Date:  2015-01-27

3.  Internet-based group contingency management to promote abstinence from cigarette smoking: a feasibility study.

Authors:  Steven E Meredith; Michael J Grabinski; Jesse Dallery
Journal:  Drug Alcohol Depend       Date:  2011-03-16       Impact factor: 4.492

4.  Treating the partners of opioid-dependent pregnant patients: feasibility and efficacy.

Authors:  Hendrée E Jones; Michelle Tuten; Kevin E O'Grady
Journal:  Am J Drug Alcohol Abuse       Date:  2011-03-17       Impact factor: 3.829

5.  Contingent reinforcement increases cocaine abstinence during outpatient treatment and 1 year of follow-up.

Authors:  S T Higgins; C J Wong; G J Badger; D E Ogden; R L Dantona
Journal:  J Consult Clin Psychol       Date:  2000-02

6.  Financial incentives for smoking cessation among depression-prone pregnant and newly postpartum women: effects on smoking abstinence and depression ratings.

Authors:  Alexa A Lopez; Joan M Skelly; Stephen T Higgins
Journal:  Nicotine Tob Res       Date:  2015-04       Impact factor: 4.244

7.  The efficacy of escalating and fixed contingency management reinforcement on illicit drug use in opioid-dependent pregnant women.

Authors:  Melissa L Hutchinson; Margaret S Chisolm; Michelle Tuten; Jeannie-Marie S Leoutsakos; Hendrée E Jones
Journal:  Addict Disord Their Treat       Date:  2012-09

8.  Anxiety and optimism associated with gestational age at birth and fetal growth.

Authors:  Janet M Catov; Diane J Abatemarco; Nina Markovic; James M Roberts
Journal:  Matern Child Health J       Date:  2010-09

9.  Contingency management for attendance to group substance abuse treatment administered by clinicians in community clinics.

Authors:  David M Ledgerwood; Sheila M Alessi; Tressa Hanson; Mark D Godley; Nancy M Petry
Journal:  J Appl Behav Anal       Date:  2008

10.  Financial incentives for smoking cessation in pregnancy: a single-arm intervention study assessing cessation and gaming.

Authors:  Diana Ierfino; Eleni Mantzari; Julie Hirst; Tina Jones; Paul Aveyard; Theresa M Marteau
Journal:  Addiction       Date:  2015-02-26       Impact factor: 6.526

View more
  5 in total

1.  Maternal schizophrenia and adverse birth outcomes: what mediates the risk?

Authors:  Simone N Vigod; Kinwah Fung; Abigail Amartey; Emily Bartsch; Reema Felemban; Natasha Saunders; Astrid Guttmann; Maria Chiu; Lucy C Barker; Paul Kurdyak; Hilary K Brown
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2019-12-06       Impact factor: 4.328

2.  A randomized controlled trial of contingency management for smoking cessation in substance use treatment patients.

Authors:  Roberto Secades-Villa; Gema Aonso-Diego; Alba González-Roz
Journal:  Int J Clin Health Psychol       Date:  2022-05-26

Review 3.  Systematic review on use of health incentives in U.S. to change maternal health behavior.

Authors:  Yukiko Washio; Sravanthi Atreyapurapu; Yusuke Hayashi; Shantae Taylor; Katie Chang; Tony Ma; Krystyna Isaacs
Journal:  Prev Med       Date:  2021-01-27       Impact factor: 4.018

Review 4.  A contingency management approach for treatment of methamphetamine use disorder and human immunodeficiency virus antiretroviral treatment adherence in pregnancy to prevent mother-to-child transmission: a case report.

Authors:  Suzanne Turner; Maya Nader; Erin Lurie
Journal:  J Med Case Rep       Date:  2022-04-27

5.  The effectiveness of smoking cessation, alcohol reduction, diet and physical activity interventions in changing behaviours during pregnancy: A systematic review of systematic reviews.

Authors:  Nicola Heslehurst; Louise Hayes; Daniel Jones; James Newham; Joan Olajide; Louise McLeman; Catherine McParlin; Caroline de Brun; Liane Azevedo
Journal:  PLoS One       Date:  2020-05-29       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.